Short Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Increases By 184.3%
by Tristan Rich · The Markets DailyConduit Pharmaceuticals Inc. (NASDAQ:CDTTW – Get Free Report) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totaling 115,921 shares, an increase of 184.3% from the December 15th total of 40,770 shares. Based on an average trading volume of 141,392 shares, the days-to-cover ratio is presently 0.8 days. Based on an average trading volume of 141,392 shares, the days-to-cover ratio is presently 0.8 days.
Conduit Pharmaceuticals Stock Performance
CDTTW stock opened at $0.01 on Wednesday. The stock’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.01. Conduit Pharmaceuticals has a 52-week low of $0.01 and a 52-week high of $0.02.
Conduit Pharmaceuticals Company Profile
Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.